scholarly journals Dose/Exposure-Response Modeling to Support Dosing Recommendation for Phase III Development of Baricitinib in Patients with Rheumatoid Arthritis

2017 ◽  
Vol 6 (12) ◽  
pp. 804-813 ◽  
Author(s):  
Xin Zhang ◽  
Laiyi Chua ◽  
Charles Ernest ◽  
William Macias ◽  
Terence Rooney ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Phase Iii ◽  
Exposure Response ◽  
Response Modeling

scholarly journals Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components

2019 ◽  
Vol 85 (8) ◽  
pp. 1710-1718 ◽  
Author(s):  
Carla Bastida ◽  
Dolors Soy ◽  
Virginia Ruiz‐Esquide ◽  
Raimon Sanmartí ◽  
Alwin D.R. Huitema
Keyword(s):  
Rheumatoid Arthritis ◽  
Composite Measures ◽  
Exposure Response ◽  
Response Modeling

scholarly journals Population Exposure-Response Modeling Supported Selection of Naloxegol Doses in Phase III Studies in Patients With Opioid-Induced Constipation

2017 ◽  
Vol 6 (10) ◽  
pp. 705-711 ◽  
Author(s):  
Nidal Al-Huniti ◽  
Hongmei Xu ◽  
Diansong Zhou ◽  
Sergey Aksenov ◽  
Robert Fox ◽  
...  
Keyword(s):  
Phase Iii ◽  
Population Exposure ◽  
Exposure Response ◽  
Response Modeling ◽  
Phase Iii Studies ◽  
Selection Of

scholarly journals Exposure–response modeling of peficitinib efficacy in patients with rheumatoid arthritis

2021 ◽  
Vol 9 (3) ◽  
Author(s):  
Junko Toyoshima ◽  
Atsunori Kaibara ◽  
Mai Shibata ◽  
Yuichiro Kaneko ◽  
Hiroyuki Izutsu ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Exposure Response ◽  
Response Modeling

Population Approach for Exposure-Response Modeling of Golimumab in Patients With Rheumatoid Arthritis

2011 ◽  
Vol 51 (5) ◽  
pp. 639-648 ◽  
Author(s):  
Chuanpu Hu ◽  
Zhenhua Xu ◽  
Yi Zhang ◽  
Mahboob U. Rahman ◽  
Hugh M. Davis ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Population Approach ◽  
Exposure Response ◽  
Response Modeling

scholarly journals Exposure–Response Analyses of Upadacitinib Efficacy in Phase II Trials in Rheumatoid Arthritis and Basis for Phase III Dose Selection

2019 ◽  
Vol 106 (6) ◽  
pp. 1319-1327 ◽  
Author(s):  
Mohamed‐Eslam F. Mohamed ◽  
Ben Klünder ◽  
Heidi S. Camp ◽  
Ahmed A. Othman
Keyword(s):  
Rheumatoid Arthritis ◽  
Phase Ii ◽  
Phase Iii ◽  
Phase Ii Trials ◽  
Dose Selection ◽  
Exposure Response
Sign in / Sign up

Export Citation Format

Share Document